H. Fredrick Bowman, Ph.D., President, Chairman & CEO, is the inventor of the Company's technology, and co-founder of Hemedex. Dr. Bowman is also the Senior Academic Administrator at the Harvard-MIT Division of Health Sciences and Technology, and a lecturer on Radiation Oncology at Harvard Medical School. He has served for 25 years as a member of the Mechanical and Biomedical Engineering faculties at Northeastern University, and as Program Director for Biomedical Engineering at the National Science Foundation. His principal research interests include microprocessor-based instrumentation for the quantification of perfusion, thermal properties and cardiac output, bioheat and mass transfer based problems in clinical research, thermal physics of hyperthermia, and thermometry. He is the author of over 120 publications and abstracts.
Lisa J. Coffey, Director of Operations, joined Hemedex Inc. in 2005. Ms. Coffey has extensive experience in organizational development and systems development for startup companies and rapid growth businesses. Prior to joining Hemedex, she spent twenty plus years developing biotechnology and medical devices teams and infrastructure. Among them Genzyme, ImmunoGen and Millennium Pharmaceuticals, as well as project development for Brown University and The Miriam Hospital. Ms Coffey has extensive experience in manufacturing and cost accounting as well as managing the scale up process. Ms Coffey managed several NIH and Darpa grants and co-wrote and received funding on a multi phase, multi year NIST grant. She has been responsible for the successful development and implementation of various teams including scientific, bioinformatic, finance & accounting, operations and administration.
James L. Neal, Chief Legal Counsel, is an experienced attorney in corporate, commercial and patent law. He has 15 years experience serving as Chief Legal Council for a major technology company, 8 years experience in private practice and has served as Patent Counsel for several US companies. Mr. Neal is a co-founder of Hemedex where he oversees the development of intellectual property and legal affairs. Prior to Hemedex, he served as Corporate Counsel at Thermo Electron Corporation, a multinational provider of products and services in the energy, environmental and biomedical fields. He was also formerly a patent attorney at Westvaco and Polaroid Corporations. Mr. Neal has a B.S. degree in Civil Engineering from North Carolina State University and a Juris Doctorate (Law) from American University in Washington, D.C.
Daniel A. Sidney, Corporate Director, received a B.A. in Molecular Biophysics & Biochemistry from Yale University, and an M.S. in Mechanical Engineering and a Ph.D. in Medical Engineering from MIT. He has worked in several medical device companies, including as Senior Project Engineer at Thermal Technologies, a Hemedex affiliate; and as Scientist at TomoTherapy, maker of the Hi-Art System for radiation therapy. He has publication in areas of bioheat transfer and respiratory control.
Ray Sidney, Ph.D., member of the Board of Directors, received his bachelor's degree from Harvard University in mathematics and his Ph.D. from the Massachusetts Institute of Technology in the field of cryptography. Before joining Hemedex's Board of Directors, Ray worked in the software industry at Google, Inc., where he was the second engineer hired. Prior to his employment at Google, Ray worked at D. E. Shaw & Co., L.P. and RSA Labs.
[ TOP ]